Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
02 08 2021
Historique:
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 17 8 2021
Statut: epublish

Résumé

To compare admission characteristics, predictors and outcomes of patients with confirmed coronavirus disease 2019 (COVID-19) hospitalised in a tertiary care hospital in Switzerland during the first and second waves of the pandemic. This retrospective observational analysis included adult patients with  severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection confirmed by a real-time reverse transcriptase polymerase chain reaction (RT-PCR) or rapid antigen test and hospitalised at the Cantonal Hospital Aarau from 26 February to 30 April 2020 (first wave) and from 1 October to 31 December 2020 (second wave). The primary endpoint was all-cause in-hospital mortality. The secondary endpoints were transfer to the intensive care unit (ICU) and length of hospital stay (LOS). Overall, 486 patients (mean age 65.9 years ± 14.7 SD, 65% male) were included. Ninety-two patients (19%) died during the hospital stay and 92 patients (19%) were transferred to the ICU. Admission characteristics, including comorbidities and frailty, were similar for patients of the first (n = 100) and second wave (n = 386). However, during the second wave the median time from symptom onset to presentation to the emergency department (ED) was shorter (7 days, interquartile range [IQR] 4–9 vs 8 days, IQR 4–11; p = 0.02). In the second wave, most patients received high-dose glucocorticoid treatment (0% vs 76%, p <0.01). In-hospital mortality was similar among COVID-19 patients in the first (19/100, 19%) and second wave (73/386, 19%); this finding persisted after full adjustment in multiple regression models (adjusted odds ratio [aOR] 1.18, 95% confidence interval [CI] 0.49–2.80; p = 0.71). Risk for ICU admission was also similar (24% vs 18%; aOR 0.98, 95% CI 0.46–2.06; p = 0.95). More patients were transferred to rehabilitation facilities in the second wave (18% vs 31%; aOR 2.06, 95% CI 1.04–4.07; p = 0.04) and LOS was 2.5 days shorter (9.0 vs 6.5 days; adjusted difference −2.53 days, 95%-CI −4.51 to −0.54; p = 0.01). Main predictors for in-hospital death were patient age (aOR 1.07, 95% CI 1.02–1.11; p <0.01), male sex (aOR 2.41, 95% CI 1.05–5.55; p = 0.04) and the age-adjusted Charlson comorbidity index (aOR 1.27, 95% CI 1.09–1.48 p <0.01). Despite differing treatment regimens, mortality and ICU admission remained largely unchanged for COVID-19 patients admitted during the second wave of the pandemic in our tertiary care hospital. However, discharge processes were optimised with patients leaving the hospital earlier and going to rehabilitation facilities more often. &nbsp.

Identifiants

pubmed: 34375985
doi: 10.4414/smw.2021.20569
pii: Swiss Med Wkly. 2021;151:w20569
doi:
pii:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20569

Commentaires et corrections

Type : CommentOn

Auteurs

Selina Wolfisberg (S)

Department of Medicine, Kantonsspital Aarau, Switzerland.

Claudia Gregoriano (C)

Department of Medicine, Kantonsspital Aarau, Switzerland.

Tristan Struja (T)

Department of Medicine, Kantonsspital Aarau, Switzerland.

Alexander Kutz (A)

Department of Medicine, Kantonsspital Aarau, Switzerland.

Daniel Koch (D)

Department of Medicine, Kantonsspital Aarau, Switzerland.

Luca Bernasconi (L)

Institute of Laboratory Medicine, Kantonsspital Aarau, Switzerland.

Angelika Hammerer-Lercher (A)

Institute of Laboratory Medicine, Kantonsspital Aarau, Switzerland.

Christine Mohr (C)

Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.

Sebastian Haubitz (S)

Department of Medicine, Kantonsspital Aarau, Switzerland / Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.

Anna Conen (A)

Department of Medicine, Kantonsspital Aarau, Switzerland / Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.

Christoph Fux (C)

Department of Medicine, Kantonsspital Aarau, Switzerland / Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.

Beat Mueller (B)

Department of Medicine, Kantonsspital Aarau, Switzerland / Medical Faculty, University of Basel, Switzerland.

Philipp Schuetz (P)

Department of Medicine, Kantonsspital Aarau, Switzerland / Medical Faculty, University of Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH